Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Tuberculosis D014376 20 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Insulinoma D007340 28 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Pulli I et al. A novel chimeric aequorin fused with caveolin-1 reveals a sphingosine kinase 1-regulated Ca²⁺ microdomain in the caveolar compartment. 2015 Biochim. Biophys. Acta pmid:25892494
Donati C et al. New insights into the role of sphingosine 1-phosphate and lysophosphatidic acid in the regulation of skeletal muscle cell biology. 2013 Biochim. Biophys. Acta pmid:22877992
Cuvillier O Sphingosine in apoptosis signaling. 2002 Biochim. Biophys. Acta pmid:12531549
Xiang SY et al. Lysophospholipid receptor activation of RhoA and lipid signaling pathways. 2013 Biochim. Biophys. Acta pmid:22986288
Taha TA et al. A house divided: ceramide, sphingosine, and sphingosine-1-phosphate in programmed cell death. 2006 Biochim. Biophys. Acta pmid:17161984
Kurano M et al. Induction of insulin secretion by apolipoprotein M, a carrier for sphingosine 1-phosphate. 2014 Biochim. Biophys. Acta pmid:24814049
Orr Gandy KA and Obeid LM Targeting the sphingosine kinase/sphingosine 1-phosphate pathway in disease: review of sphingosine kinase inhibitors. 2013 Biochim. Biophys. Acta pmid:22801037
Saba JD and de la Garza-Rodea AS S1P lyase in skeletal muscle regeneration and satellite cell activation: exposing the hidden lyase. 2013 Biochim. Biophys. Acta pmid:22750505
Goetzl EJ et al. Regulation of the roles of sphingosine 1-phosphate and its type 1 G protein-coupled receptor in T cell immunity and autoimmunity. 2008 Biochim. Biophys. Acta pmid:18381082
Maceyka M et al. Sphingosine kinase, sphingosine-1-phosphate, and apoptosis. 2002 Biochim. Biophys. Acta pmid:12531554
Brewer JW Phospholipids: "greasing the wheels" of humoral immunity. 2013 Biochim. Biophys. Acta pmid:23051607
Takuwa Y et al. Sphingosine-1-phosphate signaling and biological activities in the cardiovascular system. 2008 Biochim. Biophys. Acta pmid:18472021
Chen J et al. Deletion of sphingosine kinase 1 ameliorates hepatic steatosis in diet-induced obese mice: Role of PPARγ. 2016 Biochim. Biophys. Acta pmid:26615875
Kihara A and Igarashi Y Production and release of sphingosine 1-phosphate and the phosphorylated form of the immunomodulator FTY720. 2008 Biochim. Biophys. Acta pmid:18555808
Catarzi S et al. Redox regulation of ERK1/2 activation induced by sphingosine 1-phosphate in fibroblasts: involvement of NADPH oxidase and platelet-derived growth factor receptor. 2011 Biochim. Biophys. Acta pmid:21256191
Takuwa Y Subtype-specific differential regulation of Rho family G proteins and cell migration by the Edg family sphingosine-1-phosphate receptors. 2002 Biochim. Biophys. Acta pmid:12069818
Pyne S and Pyne NJ Sphingosine 1-phosphate signalling and termination at lipid phosphate receptors. 2002 Biochim. Biophys. Acta pmid:12069819
Okajima F Plasma lipoproteins behave as carriers of extracellular sphingosine 1-phosphate: is this an atherogenic mediator or an anti-atherogenic mediator? 2002 Biochim. Biophys. Acta pmid:12069820
Meyer zu Heringdorf D et al. Sphingosylphosphorylcholine-biological functions and mechanisms of action. 2002 Biochim. Biophys. Acta pmid:12069827
Panetti TS Differential effects of sphingosine 1-phosphate and lysophosphatidic acid on endothelial cells. 2002 Biochim. Biophys. Acta pmid:12069828
Siess W Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-1-phosphate. 2002 Biochim. Biophys. Acta pmid:12069830
Karliner JS Lysophospholipids and the cardiovascular system. 2002 Biochim. Biophys. Acta pmid:12069831
English D et al. Lipid mediators of angiogenesis and the signalling pathways they initiate. 2002 Biochim. Biophys. Acta pmid:12069833
Pyne NJ et al. Role of sphingosine 1-phosphate and lysophosphatidic acid in fibrosis. 2013 Biochim. Biophys. Acta pmid:22801038
Karunakaran I and van Echten-Deckert G Sphingosine 1-phosphate - A double edged sword in the brain. 2017 Biochim. Biophys. Acta pmid:28315304
Castillo-Badillo JA et al. Sphingosine 1-phosphate-mediated α1B-adrenoceptor desensitization and phosphorylation. Direct and paracrine/autocrine actions. 2012 Biochim. Biophys. Acta pmid:22019450
Fujii Y et al. Lymphopenia induced by a novel selective S1P(1) antagonist structurally unrelated to S1P. 2012 Biochim. Biophys. Acta pmid:22265714
Brunati AM et al. Cross-talk between PDGF and S1P signalling elucidates the inhibitory effect and potential antifibrotic action of the immunomodulator FTY720 in activated HSC-cultures. 2008 Biochim. Biophys. Acta pmid:18157950
Samadi N et al. Regulation of lysophosphatidate signaling by autotaxin and lipid phosphate phosphatases with respect to tumor progression, angiogenesis, metastasis and chemo-resistance. 2011 Biochimie pmid:20709140
Xia JY et al. The adipokine/ceramide axis: key aspects of insulin sensitization. 2014 Biochimie pmid:23969158
Leong WI and Saba JD S1P metabolism in cancer and other pathological conditions. 2010 Biochimie pmid:20167244
De Luca T et al. NAD+/NADH and/or CoQ/CoQH2 ratios from plasma membrane electron transport may determine ceramide and sphingosine-1-phosphate levels accompanying G1 arrest and apoptosis. 2005 Biofactors pmid:16873929
González-Fernández B et al. Inhibition of the SphK1/S1P signaling pathway by melatonin in mice with liver fibrosis and human hepatic stellate cells. 2017 Biofactors pmid:27801960
De Luca T et al. Downstream targets of altered sphingolipid metabolism in response to inhibition of ENOX2 by phenoxodiol. 2008 Biofactors pmid:19734127
Takuwa Y et al. Sphingosine-1-phosphate signaling in physiology and diseases. 2012 Sep-Oct Biofactors pmid:22674845
Jernigan PL et al. The role of sphingolipids in endothelial barrier function. 2015 Biol. Chem. pmid:25867999
Nojima H et al. Sphingolipids in liver injury, repair and regeneration. 2015 Biol. Chem. pmid:25781682
Zhang DD et al. Antinociceptive effects of FTY720 during trauma-induced neuropathic pain are mediated by spinal S1P receptors. 2015 Biol. Chem. pmid:25720064
Schröder M et al. Subcellular distribution of FTY720 and FTY720-phosphate in immune cells - another aspect of Fingolimod action relevant for therapeutic application. 2015 Biol. Chem. pmid:25720062
Koch A et al. Downregulation of sphingosine 1-phosphate (S1P) receptor 1 by dexamethasone inhibits S1P-induced mesangial cell migration. 2015 Biol. Chem. pmid:25719311
Pyne NJ and Kolesnick RN The life and work of Dr. Robert Bittman (1942-2014). 2015 Biol. Chem. pmid:25473803
Prüfer N et al. The role of serum amyloid A and sphingosine-1-phosphate on high-density lipoprotein functionality. 2015 Biol. Chem. pmid:25252751
Blaukat A and Dikic I Activation of sphingosine kinase by the bradykinin B2 receptor and its implication in regulation of the ERK/MAP kinase pathway. 2001 Biol. Chem. pmid:11258664
van der Giet M et al. Relevance and potential of sphingosine-1-phosphate in vascular inflammatory disease. 2008 Biol. Chem. pmid:18925828
Facchinetti MM et al. Differential branching of the sphingolipid metabolic pathways with the stage of development. Involvement of sphingosine kinase. 2003 Biol. Neonate pmid:14504448
Yonesu K et al. A novel sphingosine-1-phosphate receptor 1 antagonist prevents the proliferation and relaxation of vascular endothelial cells by sphingosine-1-phosphate. 2010 Biol. Pharm. Bull. pmid:20823564
Kotani T et al. Altered expression of enzymes regulating the activity of endothelin-1 in the lower segment of the human amnion during labor. 2013 Biol. Reprod. pmid:23863409
Dunlap KA et al. The sphingosine 1-phosphate (S1P) signaling pathway is regulated during pregnancy in sheep. 2010 Biol. Reprod. pmid:20107206
Hemmings DG et al. Sphingosine-1-phosphate acts via rho-associated kinase and nitric oxide to regulate human placental vascular tone. 2006 Biol. Reprod. pmid:16162874
Becker S et al. Follicular fluid high-density lipoprotein-associated sphingosine 1-phosphate (S1P) promotes human granulosa lutein cell migration via S1P receptor type 3 and small G-protein RAC1. 2011 Biol. Reprod. pmid:20980685
Yamamoto Y et al. Increased expression of enzymes for sphingosine 1-phosphate turnover and signaling in human decidua during late pregnancy. 2010 Biol. Reprod. pmid:20007411
Hudson NK et al. Modulation of human arterial tone during pregnancy: the effect of the bioactive metabolite sphingosine-1-phosphate. 2007 Biol. Reprod. pmid:17409372
Otala M et al. Protection from radiation-induced male germ cell loss by sphingosine-1-phosphate. 2004 Biol. Reprod. pmid:14613902
Roth Z and Hansen PJ Sphingosine 1-phosphate protects bovine oocytes from heat shock during maturation. 2004 Biol. Reprod. pmid:15317688
Wacker BK et al. Delivery of sphingosine 1-phosphate from poly(ethylene glycol) hydrogels. 2006 Biomacromolecules pmid:16602758
Das A et al. The promotion of mandibular defect healing by the targeting of S1P receptors and the recruitment of alternatively activated macrophages. 2013 Biomaterials pmid:24064148
Tengood JE et al. Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis. 2010 Biomaterials pmid:20674008
Sefcik LS et al. Sustained release of sphingosine 1-phosphate for therapeutic arteriogenesis and bone tissue engineering. 2008 Biomaterials pmid:18405965
Wang J et al. Local delivery of FTY720 in PCL membrane improves SCI functional recovery by reducing reactive astrogliosis. 2015 Biomaterials pmid:26036174
Serebrov VIu et al. [Activity of the sphingomyelin cycle enzymes and concentration of products of sphingomyelin degradation in the rat liver in the course of acute toxic hepatitis]. 2010 Mar-Apr Biomed Khim pmid:21341516
Zankov DP and Ogita H Actin-tethered junctional complexes in angiogenesis and lymphangiogenesis in association with vascular endothelial growth factor. 2015 Biomed Res Int pmid:25883953
Carrera I et al. A comparative evaluation of a novel vaccine in APP/PS1 mouse models of Alzheimer's disease. 2015 Biomed Res Int pmid:25759822
Mierzejewska K et al. Sphingosine-1-phosphate-mediated mobilization of hematopoietic stem/progenitor cells during intravascular hemolysis requires attenuation of SDF-1-CXCR4 retention signaling in bone marrow. 2013 Biomed Res Int pmid:24490172
Nagahashi M et al. Sphingosine-1-phosphate transporters as targets for cancer therapy. 2014 Biomed Res Int pmid:25133174
Wang Z et al. Decreased Splenic CD4(+) T-Lymphocytes in Apolipoprotein M Gene Deficient Mice. 2015 Biomed Res Int pmid:26543853
Flávia Nardy A et al. Modulation of Intrathymic Sphingosine-1-Phosphate Levels Promotes Escape of Immature Thymocytes to the Periphery with a Potential Proinflammatory Role in Chagas Disease. 2015 Biomed Res Int pmid:26347020
Müller J et al. Differential S1P Receptor Profiles on M1- and M2-Polarized Macrophages Affect Macrophage Cytokine Production and Migration. 2017 Biomed Res Int pmid:28367448
Jiang Z et al. Metabonomic study on women of reproductive age treated with nutritional intervention: screening potential biomarkers related to neural tube defects occurrence. 2011 Biomed. Chromatogr. pmid:20812204
Lan T et al. Determination of sphingosine kinase activity in biological samples by liquid chromatography-tandem mass spectrometry. 2010 Biomed. Chromatogr. pmid:20352614
Bassoy EY and Baran Y Bioactive sphingolipids in docetaxel-induced apoptosis in human prostate cancer cells. 2012 Biomed. Pharmacother. pmid:22326625
Don AS et al. Re-configuration of sphingolipid metabolism by oncogenic transformation. 2014 Biomolecules pmid:24970218
Raje MR et al. Design, synthesis and biological activity of sphingosine kinase 2 selective inhibitors. 2012 Bioorg. Med. Chem. pmid:22137932
Nakamura T et al. Synthesis and SAR studies of a novel class of S1P1 receptor antagonists. 2007 Bioorg. Med. Chem. pmid:17379528
Kim JW et al. Synthesis and evaluation of sphingoid analogs as inhibitors of sphingosine kinases. 2005 Bioorg. Med. Chem. pmid:15848761
Qiao L et al. Synthesis and evaluation of a photolyzable derivative of sphingosine 1-phosphate--caged SPP. 1998 Bioorg. Med. Chem. Lett. pmid:9871527
Hanessian S et al. Constrained azacyclic analogues of the immunomodulatory agent FTY720 as molecular probes for sphingosine 1-phosphate receptors. 2007 Bioorg. Med. Chem. Lett. pmid:17070046
Hale JJ et al. Potent S1P receptor agonists replicate the pharmacologic actions of the novel immune modulator FTY720. 2004 Bioorg. Med. Chem. Lett. pmid:15149705
Lim HS et al. Syntheses of sphingosine-1-phosphate analogues and their interaction with EDG/S1P receptors. 2004 Bioorg. Med. Chem. Lett. pmid:15109640
Kurata H et al. Structure-activity relationship studies of S1P agonists with a dihydronaphthalene scaffold. 2012 Bioorg. Med. Chem. Lett. pmid:22153936
Lim HS et al. Syntheses of sphingosine-1-phosphate stereoisomers and analogues and their interaction with EDG receptors. 2003 Bioorg. Med. Chem. Lett. pmid:12482430
Pennington LD et al. Quinolinone-based agonists of S1P₁: use of a N-scan SAR strategy to optimize in vitro and in vivo activity. 2012 Bioorg. Med. Chem. Lett. pmid:22104144
Yan L et al. 2-Aryl(pyrrolidin-4-yl)acetic acids are potent agonists of sphingosine-1-phosphate (S1P) receptors. 2006 Bioorg. Med. Chem. Lett. pmid:16621543
De Jonghe S et al. Structure-activity relationship of short-chain sphingoid bases as inhibitors of sphingosine kinase. 1999 Bioorg. Med. Chem. Lett. pmid:10560747
Evindar G et al. Synthesis and evaluation of alkoxy-phenylamides and alkoxy-phenylimidazoles as potent sphingosine-1-phosphate receptor subtype-1 agonists. 2009 Bioorg. Med. Chem. Lett. pmid:19081720
Antoon JW and Beckman BS Anti-proliferative effects of the novel ceramide analog (S)-2-(benzylideneamino)-3-hydroxy-N-tetrade-cylpropanamide in chemoresistant cancer. 2012 Bioorg. Med. Chem. Lett. pmid:22366655
Foss FW et al. Synthesis, stability, and implications of phosphothioate agonists of sphingosine-1-phosphate receptors. 2005 Bioorg. Med. Chem. Lett. pmid:16125386
Guo J et al. Identification and synthesis of potent and selective pyridyl-isoxazole based agonists of sphingosine-1-phosphate 1 (S1P1). 2016 Bioorg. Med. Chem. Lett. pmid:27055941
Evindar G et al. Exploring amino acids derivatives as potent, selective, and direct agonists of sphingosine-1-phosphate receptor subtype-1. 2013 Bioorg. Med. Chem. Lett. pmid:23245510
Xiang Y et al. Discovery of novel sphingosine kinase 1 inhibitors. 2009 Bioorg. Med. Chem. Lett. pmid:19800228
Murakami T et al. Synthesis and biological properties of novel sphingosine derivatives. 2005 Bioorg. Med. Chem. Lett. pmid:15686924
Jensen T et al. The identification of GPR3 inverse agonist AF64394; the first small molecule inhibitor of GPR3 receptor function. 2014 Bioorg. Med. Chem. Lett. pmid:25442311
Clemens JJ et al. Synthesis of para-alkyl aryl amide analogues of sphingosine-1-phosphate: discovery of potent S1P receptor agonists. 2003 Bioorg. Med. Chem. Lett. pmid:14505636
Evindar G et al. Exploration of amino alcohol derivatives as novel, potent, and highly selective sphingosine-1-phosphate receptor subtype-1 agonists. 2010 Bioorg. Med. Chem. Lett. pmid:20304639
Clemens JJ et al. Synthesis of 4(5)-phenylimidazole-based analogues of sphingosine-1-phosphate and FTY720: discovery of potent S1P1 receptor agonists. 2005 Bioorg. Med. Chem. Lett. pmid:15982878
Clemens JJ et al. Synthesis of benzimidazole based analogues of sphingosine-1-phosphate: discovery of potent, subtype-selective S1P4 receptor agonists. 2004 Bioorg. Med. Chem. Lett. pmid:15341948
Hakogi T et al. Synthesis of fluorescence-labeled sphingosine and sphingosine 1-phosphate; effective tools for sphingosine and sphingosine 1-phosphate behavior. 2003 Bioorg. Med. Chem. Lett. pmid:12639553
Ma B et al. Stereochemistry-activity relationship of orally active tetralin S1P agonist prodrugs. 2010 Bioorg. Med. Chem. Lett. pmid:20188554
Ohno T et al. The prediction of human response to ONO-4641, a sphingosine 1-phosphate receptor modulator, from preclinical data based on pharmacokinetic-pharmacodynamic modeling. 2010 Biopharm Drug Dispos pmid:20623701
Wacker BK et al. Endothelial cell migration on RGD-peptide-containing PEG hydrogels in the presence of sphingosine 1-phosphate. 2008 Biophys. J. pmid:17827231
García-Pacios M et al. Sphingosine-1-phosphate as an amphipathic metabolite: its properties in aqueous and membrane environments. 2009 Biophys. J. pmid:19720028